Abstract
Osteoporosis is the most common metabolic bone disease, and its clinical manifestations result from skeletal fractures. This disease poses a high risk of morbidity and mortality and represents a tremendous economic burden to society. The Dual Energy Absorptiometry Scan (DXA) is the gold standard for diagnosis, and the Fracture Risk Assessment Tool (FRAX) helps in deciding therapeutic interventions in those with osteopenia. The most important management strategy is fracture prevention and treating contributing factors. Both non-pharmacologic and pharmacologic therapies, including patient and provider education, are effective in decreasing the morbidity and mortality of osteoporosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
https://www.iofbonehealth.org/facts-and-statistics/calcium-studies-map.
http://www.twinsuk.ac.uk/wp-content/uploads/2012/03/Zhai.-Osteoporosis.-2008.pdf.
National Osteoporosis Foundation. https://cdn.nof.org/wp-content/uploads/2015/12/Osteoporosis-Fast-Facts.pdf.
Kostenuik PJ. Curr Opin Pharmacol. 2005;5:618–25; Boyle WJ, et al. Nature. 2003;423:337–42; Kostenuik PJ, et al. Curr Pharm Des. 2001;7:613–35.
Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA. Long-term anticonvulsant therapy leads to low bone mineral density–evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes. 2000;108(1):37–43. https://www.iofbonehealth.org/facts-and-statistics/calcium-studies-map
Albertazzi P, Bottazzi M, Steel SA. Bone mineral density and depot medroxyprogesterone acetate. Contraception. 2006;73(6):577–83. Epub 2006 Apr 27.
https://www.iscd.org/publications/osteoflash/osteoporosis-in-men/.
Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650040803.
https://www.iscd.org/documents/2014/10/nof-clin-guidelines.pdf/.
Carmel AS, Shieh A, Bang H, Bockman RS. The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml. Osteoporos Int. 2012;23(10):2479–87. https://doi.org/10.1007/s00198-011-1868-7. Epub 2012 Jan 12.
Watts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, Smith S, Zack DJ, Zhou L, Grauer A, Ferrari S. Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? Osteoporos Int. 2012;23(1):327–337. https://doi.org/10.1007/s00198-011-1755-2. Epub 2011 Sep 3.
Andrews EB, Gilsenan AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res. 2012;27(12):2429–37. https://doi.org/10.1002/jbmr.1768.
https://www.rheumatology.org/Portals/0/Files/Guideline-for-the-Prevention-and-Treatment-of-GIOP.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Haridas, A., Berney, S.M. (2020). Osteoporosis. In: Efthimiou, P. (eds) Absolute Rheumatology Review. Springer, Cham. https://doi.org/10.1007/978-3-030-23022-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-23022-7_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23021-0
Online ISBN: 978-3-030-23022-7
eBook Packages: MedicineMedicine (R0)